She felt awful for the rest of the day
Introducing Our Latest White Paper: Orforglipron: A Next-Generation Oral GLP-1 Agonist Were proud to share our newest research spotlighting Orforglipron, an innovative oral GLP-1 agonist poised to transform diabetes and obesity management

Individuals who may be at greater risk include: Those with a pre-existing diagnosis of osteoarthritis, rheumatoid arthritis, or other inflammatory joint conditions Patients with obesity-related joint loading, particularly affecting the knees, hips, and lower back Older adults, in whom musculoskeletal complaints are more prevalent at baseline Individuals experiencing rapid weight loss, which may transiently alter joint mechanics and gait, particularly in the lower limbs this is a theoretical consideration based on general musculoskeletal principles rather than retatrutide-specific evidence Significant weight reduction one of retatrutide's primary therapeutic effects is generally associated with reduced mechanical load on weight-bearing joints , which may improve joint symptoms over time in individuals with obesity-related arthropathy
What is bariatric surgery
With MASH serving as a leading cause of liver transplants globally, this regulatory fast-track offers immense hope for millions lacking viable treatment options